The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results...

by Jose E. Batista, Heinz Kölbl, Sender Herschorn, Tomasz Rechberger, Javier Cambronero, Michael Halaska, Alex Coppell, Mathilde Kaper, Moses Huang, Emad Siddiqui
Published 2015-08-01

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies

by Andrea Tubaro, José E. Batista, Victor W. Nitti, Sender Herschorn, Christopher R. Chapple, Mary Beth Blauwet, Emad Siddiqui, Moses Huang, Matthias Oelke
Published 2017-06-01